Diagnostic procedures
ApprovedTerminated 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Anterior Ischemic Optic Neuropathy
Conditions
Anterior Ischemic Optic Neuropathy
Trial Timeline
Jul 13, 2009 → Mar 28, 2018
NCT ID
NCT00867815About Diagnostic procedures
Diagnostic procedures is a approved stage product being developed by Bayer for Anterior Ischemic Optic Neuropathy. The current trial status is terminated. This product is registered under clinical trial identifier NCT00867815. Target conditions include Anterior Ischemic Optic Neuropathy.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00867815 | Approved | Terminated |
Competing Products
9 competing products in Anterior Ischemic Optic Neuropathy
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| PDE5 Inhibitors | Eli Lilly | Pre-clinical | 23 |
| Rosuvastatin | AstraZeneca | Approved | 85 |
| MSB-CAR001 Combined With Hyaluronan + Hyaluronan | Mesoblast | Phase 1/2 | 36 |
| Topical Prednisolone Acetate 1% | Ocular Therapeutix | Approved | 80 |
| OMS103HP + Vehicle | Omeros Corporation | Phase 3 | 72 |
| Valganciclovir Hydrochloride + Ganciclovir Sodium + Placebo Oral Tablet + Topical placebo | Pacific Biosciences | Phase 2/3 | 57 |
| Abciximab local infusion | Atrium Therapeutics | Pre-clinical | 15 |
| ADX-102 Ophthalmic Solution (0.5%) + Vehicle of ADX-102 Ophthalmic Solution | Aldeyra Therapeutics | Phase 3 | 69 |
| NS2 + Prednisolone acetate ophthalmic suspension (1%) | Aldeyra Therapeutics | Phase 2 | 44 |